FDA Moves to Pull Avastin Breast Cancer Approval

The FDA has moved to withdraw its approval of Avastin for treating metastatic breast cancer. Avastin is still approved for other cancers. Roche/Genentech will fight the decision at an FDA hearing.

Read the original here:

FDA Moves to Pull Avastin Breast Cancer Approval

Posted by on December 16, 2010. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry